Metoprolol in the Prophylaxis of Migraine: Parallel‐Groups Comparison withPlacebo and Dose‐Ranging Follow‐Up
The DOI matches its Crossref record.
Abstract
SYNOPSIS 88 patients in need of prophylactic treatment for classical, common or mixed migraine of at least 2years' duration were admitted to a double‐blind placebo‐controlled trial of the beta1‐selective adrenoceptorblocker, metoprolol. All patients initially took placebo for 1 month, during which 29 were excludedprincipally because of failure to reattend or placebo‐response making active treatment unnecessary. Theremaining 59 patients were randomised to continued placebo or metoprolol 50 mg b.i.d. for 2 months.Patients after this time subjectively categorizing their responses as less than optimal changed,double‐blindly, from placebo to metoprolol 50 mg b.i.d., or from metoprolol 50 mg b.i.d. to 100 mg b.i.d., fora further follow‐up period of up to 3 months. Placebo response was 40% overall, and often occurred after the first month. In the first double‐blindcomparative period metoprolol reduced attack frequency significantly, and more than placebo. Severity ofattacks still occurring was not altered by either treatment. Other measures of illness were alteredconsistently with these principal findings. Consistent improvements also were seen in patients switchingfrom initial placebo therapy to metoprolol 50 mg b.i.d. for the further follow‐up period, and those changingto the higher dose of metoprolol showed statistically significant further improvements, and clinicallyimportant improvements overall. Side‐effects were minor and reversible. This study gives supportive evidence of the value of metoprolol in preventing migraine attacks andsuggests that individual dosage titration can substantially enhance its efficacy. Side‐effects do notsignificantly impede its use and other evidence suggests that beta1‐selective blockers are to be preferredover non‐selective in migraine therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
EFNS guideline on the drug treatment of migraine—revised report of an EFNS task force
Evers, S., Áfra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., & Sándor, P. S. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02748.x · Cited by 892
A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache
Jackson, J. L., Cogbill, E., Santana-Davila, R., Eldredge, C., Collier, W., Gradall, A., Sehgal, N., & Kuester, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0130733 · Cited by 291
Migraine: Preventive Treatment
Silberstein, S., & Goadsby, P. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00386.x · Cited by 259
Vandervorst, F., Van Deun, L., Van Dycke, A., Paemeleire, K., Reuter, U., Schoenen, J., & Versijpt, J. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01335-2 · Cited by 121
β-blockers: Their new life from hypertension to cancer and migraine
Fumagalli, C., Maurizi, N., Marchionni, N., & Fornasari, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104587 · Cited by 102
Metadata
- Authors
- Steiner, T. J., Joseph, R., Hedman, C., & Rose, F. C.
- Venue
- Headache: The Journal of Head and Face Pain
- Publisher
- Wiley
- Published
- 1988-02
- Volume
- 28
- Issue
- 1
- Pages
- 15-23
- ISSN
- 0017-8748 (ISSN-L)
- 1526-4610
- OpenAlex
- W2084509319
- Cited by
- 63
- References
- 0
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metoprolol in the Prophylaxis of Migraine: Parallel‐Groups Comparison withPlacebo and Dose‐Ranging Follow‐Up. https://app.cochat.ai/papers/10.1111/j.1365-2524.1988.hed2801015.x
- The paper
- Steiner, T. J., Joseph, R., Hedman, C., & Rose, F. C. (1988). Metoprolol in the Prophylaxis of Migraine: Parallel‐Groups Comparison withPlacebo and Dose‐Ranging Follow‐Up. Headache: The Journal of Head and Face Pain. https://doi.org/10.1111/j.1365-2524.1988.hed2801015.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.